Sofinnova Raises €472m To Build Europe’s Biggest Early-Stage Investment Fund

Reflects Booming Global Life Sciences VC Sector

Euros in test tube
Investment in Europe's sector is growing fast, with global biopharma VC fundraising set to break records in 2021. • Source: Getty Images

More from Business

More from Scrip